Veracyte's Shares Rise Sharply in December, but MDx/Omics Tools Stocks Decline Slightly | GenomeWeb

NEW YORK (GenomeWeb) – Shares of Veracyte were up 48 percent month over month in December pacing the gainers in the GenomeWeb Daily News Index, which overall was essentially flat during the month. 

The GWDN Index was down a fraction of 1 percent from November despite the large gain by Veracyte, as well as significant jumps in the shares of Vermillion (+26 percent), Sequenom (+23 percent), and GenMark Diagnostics (+20 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.